Qilu Antibiotics Pharmaceutical Co., Ltd.

Jinan, ChinaFEI 3009831352API manufacture registered

Qilu Antibiotics Pharmaceutical Co., Ltd. is a drug establishment in Jinan, China, registered with the US FDA under FEI 3009831352. Its registered operations are: Analytical testing, API manufacture, Labelling, Drug manufacture, Packaging. 8 EU/UK GMP certificates are matched to this site, 4 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testingAPI manufactureLabellingDrug manufacturePackaging

GMP documents matched to this site (8)

DocumentAuthorityInspectionSource
482709-105120520
GMP certificate
Competent authority of Austria26 Jun 2026
within 3-year review window
EudraGMDP
DE_BY_05_GMP_2024_0059
GMP certificate
Competent authority of Germany31 May 2024
within 3-year review window
EudraGMDP
ES/108HV/24
GMP certificate
Competent authority of Spain24 Apr 2024
within 3-year review window
EudraGMDP
ES/043HV/25
GMP certificate
Competent authority of Spain24 Apr 2024
within 3-year review window
EudraGMDP
482709-101208378
GMP certificate
Competent authority of Austria22 Sept 2023
outside 3-year review window
EudraGMDP
QILUANTIBIOTICS/2026/001
GMP certificate
Competent authority of Cyprus29 Jun 2023
outside 3-year review window
EudraGMDP
QILUANTIBIOTICS/2023/001
GMP certificate
Competent authority of Cyprus29 Jun 2023
outside 3-year review window
EudraGMDP
UK API 40128 Insp GMP 40128/4100215-0007
GMP certificate
MHRA17 Nov 2014
outside 3-year review window
MHRA-GMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.